Because of increased levels of two phosphatonins including fibroblast growth factor 23 (FGF23) [2] and prevalent vascular calcification at the initiation of dialysis, the importance of CKD-MBD is currently recognized in the predialysis phase in patients with CKD. The gene discussed is FGF23; the disease is chronic kidney disease.